On March 26, 2013

Neuropeptide W’s role in mammals’ energy balance control

Neuropeptide W may play an important central role in the feeding intake and energy balance control in mammals.

Neuropeptide W (NPW) is produced in neurons located in hypothalamus, brain stem and antral G cells and its receptors are present in the hypothalamus, in particular in the paraventricular nucleus. There are two forms of the peptide, designated as neuropeptide W-23 (NPW23) and neuropeptide W-30 (NPW30). Neuropeptide W is an endogenous ligand for G-protein-coupled receptor, GPR7 and GPR8 receptors.

We conducted this study to investigate the effects of NPW on feeding intake and energy expenditure in Wistar rats. Systemic injection of both forms of neuropeptide W (NPW23 and NPW30) to ad libitum feeding Wistar rats decreased dark feeding and fasting-induced feeding. One week of systemic treatment with NPW23 decreased feeding intake and weight gain during the treatment period. On the other hand, systemic treatment with antineuropeptide W antibody increased feeding intake. Moreover, systemic treatment with neuropeptide W-23 raised body temperature and consequently thermogenesis.

These results suggest that neuropeptide W may play an important central role in the feeding intake and energy balance control in mammals.

Source:  T. Naso et al., 2013. Central neuropeptide W has anorexigenic effect in rats. JAPAN online March 2013. doi: 10.1111/jpn.12067

Comments powered by Disqus




Read the March issue of Petfood Industry!

March 2015

The March 2015 issue of Petfood Industry focuses on emerging pet industry trends. Read about NutriFusion, a company that saw immediate growth after expanding from human food into the pet food industry with its fruit and vegetable nutrient-dense products. Also, learn about how so-called "superfoods" are trending as a new pet food ingredient, and why innovation, convenience and sustainability are key in pet food packaging.

READ MORE in Petfood Industry magazine